Table 4. | Stromal characteristics in PGCG and CGCG |
| Stromal characteristics | PGCG | CGCG | P-valuea | |
|---|---|---|---|---|
| Prominent hemorrhage or hemosiderin | 55.55% | 85.72% | 0.162 | |
| Prominent bone or osteoid formation | 11.11% | 85.72% | 0.001 | |
| Prominent fibrosis | 44.44% | 64.29% | 0.417 | |
| Prominent cellularity | 77.78% | 92.85% | 0.538 | |
| Foci of acute or chronic inflammatory cells | 33.33% | 14.28% | 0.343 | |
| Type of stromal cells | Spindle | 55.55% | 78.57% | 0.363 |
| Ovoid | 45.45% | 21.43% | ||
| Type of nuclei in giant cells | Vesicular | 44.41% | 35.71% | 1 |
| Solid | 55.59% | 64.29% | ||
| Pattern of distribution of giant cells | Diffuse | 100% | 71.42% | 0.127 |
| Focal | 0% | 28.58% | ||
| Separation of giant cells from stroma | 66.67% | 64.29% | 1 | |
aStatistically significant at the level P < 0.05 (Fisher-exact test).
|
.png)
.png)
.png)
.png)